The mechanism of salicylate ototoxicity seems to be multifactorial. Morphologic studies suggest that no permanent cochlear damage occurs with salicylate ototoxicity. Electrophysiologic ...

Inhibition of autophagy has shown significant potential in reducing cisplatin-induced ototoxicity. Several studies have demonstrated this, including the use of the autophagy inhibitor LY294002, which ...

Common ototoxic drugs (drugs that can have toxic effects on the ears) include antibiotics, analgesics (pain relievers), blood pressure medications, anticonvulsants (anti-seizure drugs), and others.' ...

ii Infants and young children that are affected by ototoxicity at critical stages of development lack speech and language development and literacy, and older children and adolescents often lack social ...

Vertigo may continue for up to four months after tumor removal. Medications: Some medications, including aminoglycoside antibiotics, chemotherapy drugs like cisplatin, diuretics, and aspirin, can ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

You may receive a combination of therapies or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted therapies ...

Exclusion criteria applied in this study encompassed patients with a history of previous otologic surgery, ototoxic drug use, a history of genetic disorders associated with familial deafness, head ...